Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review

The inclusion of patient-reported outcome (PRO) measures in chimeric antigen receptor (CAR) T-cell therapy research is critical for understanding the impact of this novel approach from a unique patient standpoint. We performed a scoping review to map the available literature on the use of PRO measur...

Descripción completa

Detalles Bibliográficos
Autores principales: Efficace, Fabio, Cannella, Laura, Sparano, Francesco, Giesinger, Johannes M., Vignetti, Marco, Baron, Frédéric, Bruera, Eduardo, Luppi, Mario, Platzbecker, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722582/
https://www.ncbi.nlm.nih.gov/pubmed/36504547
http://dx.doi.org/10.1097/HS9.0000000000000802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722582/
https://www.ncbi.nlm.nih.gov/pubmed/36504547
http://dx.doi.org/10.1097/HS9.0000000000000802

Ejemplares similares